The global tacrolimus market size is expected to grow at a significant CAGR of around 4.5% during the forecast period 2021 to 2027 and projected to reach around USD 3.4 billion by 2027. The increasing number of organ transplants around the globe is a primary factor to drive the market growth. According to the latest… Read More »
The global fluvoxamine market size was valued at USD 592 million in 2020 and projected to grow at a significant CAGR of 3% during the forecast period 2021 to 2027. The rising prevalence of anxiety and depression across the globe is a major factor to drive the market growth. Moreover, the increasing incidence of social… Read More »
The global flare gas recovery systems market size was accounted for around USD 2 billion in 2020 and projected to grow at the CAGR of 13.1% market during 2020-2027. Tightening environmental regulations to be the key drivers for global flare gas recovery systems. Growing environmental concerns over the emission of greenhouse gases among the nations… Read More »
The global angiotensin converting enzyme (ACE) market size is projected to grow at a passive CAGR of less than 1% during 2020-2027 and expected to reach over USD 12 billion in terms of revenue by 2027. The renin-angiotensin-aldos-terone system (RAAS) plays a key physiologic role in the regulation of blood pressure in the human body.… Read More »
By Product: Oxygen Nitrogen Hydrogen Carbon Dioxide Acetylene Argon Others By Application: Healthcare Manufacturing Metallurgy & Glasses Food & Beverage Retail Chemicals & Energy Others By Distribution Channel: On-site Bulk Cylinder List of Key Companies: Air Liquide S.A. Asia Technical Gas Co LTD Taiyo Nippon Sanso Corporation Linde AG Dubai Industrial Gases MATHESON Tri-Gas Inc.
By Application: Cardiovascular Diabetes Mellitus Anti-infective Others By Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies List of Key Companies: Pfizer, Inc. AstraZeneca Merck & Co., Inc. (Merck Sharp & Dohme Corp) Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Reddy’s Laboratories Ltd. Cipla, Inc. Cadila Pharmaceuticals
By Drug Class Statins PCSK9 Inhibitors Bile Acid Sequestrants Cholesterol Absorption Inhibitors Fibric Acid Derivatives Combination Symptoms Check List of Key Companies: Boehringer Ingelheim GmbH Merck KGaA Johnson and Johnson Bayer AG Pfizer, Inc. Takeda Pharmaceutical Co., Ltd. AstraZeneca plc
By Treatment: Bone Marrow Transplant Enzyme Replacement Therapy By Indication: Type I Type II Type III By End-user: Hospitals Specialty Clinics List of Key Companies: CHIESI Farmaceutici S.p.A.